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Abstract
The innate immune response is essential to the host defense against viruses, through restriction of virus replication and
coordination of the adaptive immune response. Induction of antiviral genes is a tightly regulated process initiated mainly
through sensing of invading virus nucleic acids in the cytoplasm by RIG-I like helicases, RIG-I or Mda5, which transmit the
signal through a common mitochondria-associated adaptor, MAVS. Although major breakthroughs have recently been
made, much remains unknown about the mechanisms that translate virus recognition into antiviral genes expression.
Beside the reputed detrimental role, reactive oxygen species (ROS) act as modulators of cellular signaling and gene
regulation. NADPH oxidase (NOX) enzymes are a main source of deliberate cellular ROS production. Here, we found that
NOX2 and ROS are required for the host cell to trigger an efficient RIG-I-mediated IRF-3 activation and downstream antiviral
IFNb and IFIT1 gene expression. Additionally, we provide evidence that NOX2 is critical for the expression of the central
mitochondria-associated adaptor MAVS. Taken together these data reveal a new facet to the regulation of the innate host
defense against viruses through the identification of an unrecognized role of NOX2 and ROS.
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Introduction
The capacity of the host to rapidly respond to virus infection is
essential to establish an antiviral state that restricts virus replication
and spreading, and to permit the production of proinflammatory
chemokines and cytokines that attract and activate immune cells to
the site of infection. Although major breakthroughs have recently
been made, much remains unknown in our understanding of the
molecular mechanisms involved in virus recognition and how it is
transmitted via signaling messengers to the expression of antiviral
and proinflammatory genes.
Initiation of these innate immune responses is achieved through
recognition of invading viruses by pattern recognition receptors
(PRR) that specifically recognize pathogen-associated molecular
patterns (PAMPs). Virus-derived nucleic acids are considered
major PAMPs that activate various PRRs, including members of
the membrane-bound Toll-like receptors (TLRs) family, TLR-3, -
7 and -9, and the recently identified cytoplasmic RIG-I-like
receptors (RLRs), including RIG-I and Mda5 [1]. Following
recognition of viral RNAs, RIG-I/Mda5 elicit signaling cascades
via a caspase recruitment domain (CARD)-mediated interaction
with the mitochondria-associated adaptor MAVS, also known as
CARDIF/IPS-1/VISA [1], which in turn interacts with the
TNFR-associated death domain (TRADD) protein [2]. At this
level, the signaling cascades diverge due to specific interactions
either with the FADD and RIP1 adaptors or with the E3 ubiquitin
ligase TRAF3 and the adaptor protein TANK, to elicit activation
of the NF-kB and IRF-3 transcription factors, respectively [2].
Activation of the ubiquitously expressed IRF-3 transcription
factor is central to the development of an antiviral state, mainly
through the rapid and robust expression of type I Interferons
(IFNs) genes, a prerequisite for the induction of numerous antiviral
proteins that modulate protein synthesis, growth arrest and
apoptosis [3]. Moreover, IRF-3 also has the capacity to directly
regulate a subset of these antiviral genes, including IFIT1, which
encodes for the ISG56 translation regulator, thereby establishing
an early IFN-independent antiviral response [4]. Virus-induced
IRF-3 activation relies on a complex set of phosphorylation events
mediated at least by the IkB-kinase (IKK)-related kinases, TANK
binding kinase-1 (TBK1) and IKKe, that regulates its dimeriza-
tion, nuclear accumulation and transactivation capacities [5,6].
Reactive oxygen species (ROS), such as hydrogen peroxide and
superoxideanion,arenow wellappreciatedtoactascellularswitches
for signaling cascades leading to gene regulation involved in
physiological processes, including cell proliferation, apoptosis and
immune and proinflammatory responses [7,8]. Amongst the
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oxidase/Dual oxidase (NOX/DUOX) enzymes is now considered
predominantinvariouscelltypes.Sevenmembersofthisfamilyhave
been identified, named NOX1-5 and DUOX1-2, each with tissue-
and cell-type specific expression patterns [9]. NOX2, which is
mainly expressed in, but not restricted to, neutrophils and
macrophages, is well known to play pivotal roles in host defense
against bacterial and fungal pathogens, through production of
superoxide in the phagosome [10]. Interestingly, recent functional
data have emerged that suggest the involvement of NOX/DUOX
members in the innate host defense to invading microorganisms in
non-phagocytic cells [11,12]. Particularly, a crucial role of NOX1
and NOX4 in the regulation of TLR-mediated intracellular
signaling via MAPK and NF-kB has previously been highlighted
[11,13]. More recently, NOX2 interaction with TLR2 was shown to
be required for efficient innate immune responses to Mycobacteria
[14]. Additionally, we recently reported for the first time that NOX2
plays an essential role during Paramyxoviridae virus infections through
the regulation of the NF-kB-mediated proinflammatory response in
airway epithelial cells (AEC) [15]. Here, we add a new facet to the
regulation of the antiviral response. Our data demonstrate that
NOX2 and ROS are critical for the ability of the host cell to trigger
an efficient RIG-I-mediated IRF-3 activation and downstream
antiviral genes through regulation of MAVS expression.
Results
NADPH oxidase-derived ROS are required for SeV-
induced antiviral genes regulation
To start evaluating the potential implication of NOX-derived
superoxide in IRF-3-mediated antiviral responses, the effect of
antioxidants and pharmacological inhibitors on Sendai virus (SeV)-
induced IFNb- and ISG56-promoter activities was investigated in
A549 cells. As shown in Figure 1A, SeV-induced IFNb-promoter
activity was significantly reduced in the presence of Tempol, a cell-
permeable superoxide dismutase mimetic. Consistent with an
implication of superoxide-dependent IRF-3 regulation, Tempol
also inhibited the activity of the ISRE-containing ISG56-promoter
in response to SeV (Figure 1A). Further analyses revealed that
pretreatment with diphenyleneiodonium (DPI) or apocynin (Apo),
two inhibitors classically used to target NADPH oxidase activities,
also effectively inhibited SeV-induced IFNb- (Figure 1B) and
ISG56-promoter activities (Figure 1C and D) in a dose-dependent
manner, while the same inhibitors did not similarly impact the
activity of the unrelated pEF1 promoter (Figure S1 and Text S1).
To provide further evidence on whether NADPH oxidase-
derived ROS are required for the regulation of IRF-3-dependent
antiviral genes, the expression profile of IFNb and IFIT1 (encoding
for ISG56) genes was monitored in vivo by real-time PCR during
SeV infection in the absence or presence of DPI. While IFNb and
ISG56 mRNA levels were markedly induced following SeV
infection, the mRNA levels exhibited 1.8 log and 1.6 log
reduction, respectively, in the presence of DPI (Figure 1E).
Altogether these results suggest that efficient IFNb and IFIT1
genes expression in response to SeV infection requires the
production of ROS produced by a NADPH oxidase.
Interference with NOX2 inhibits SeV-induced IFNb- and
ISG56-promoter activation
To determine whether the observed antioxidant-mediated
inhibition of SeV-induced IFNb and IFIT1 antiviral genes
expression could be linked to an effect on NOX2, the effect of
interference with NOX2 expression on their respective promoter
activities was assessed. Immunoblot for NOX2 (Figure 2A)
confirmed that NOX2 specific RNAi oligonucleotides significantly
decreased NOX2 protein expression in A549, as previously
validated and confirmed at the mRNA level [15], without
affecting cellular viability (Figure S2 and Text S1). Reduction of
NOX2 expression effectively altered the gene transactivation
capacity of endogenous IRF-3. First, the stimulation of IFNß- and
ISG56-promoter activities by SeV were dramatically decreased in
NOX2-depleted cells compared to cells transfected with CTRL
RNAi (Figure 2B). Second, ectopic expression of NOX2
significantly enhanced SeV-induced activation of the IFNb
promoter (Figure 2C). Additionally, to further establish the role
of NOX2 in vivo, the expression of endogenous IFNb was analyzed
by real-time PCR following SeV infection of CTRL- and NOX2-
RNAi-transfected cells. SeV-induced IFNb mRNA level was
significantly reduced by 53% in the absence of NOX2 as
compared to control cells, while SeV replication quantified by
real-time PCR analysis of the nucleocapside (N) RNA revealed a
1.6 fold increase (Figure 2D). Taken together, these results
demonstrate that NOX2 contributes to the regulation of SeV-
induced IFNb- and ISG56-promoter activities, thereby suggesting
that NOX2 is an essential component of the signaling pathway
triggering IRF-3 activation following virus infection.
SeV-induced IRF-3 activation is dependent on NOX2 and
ROS production
In uninfected cells, IRF-3 is predominantly present as two forms
corresponding to an unphosphorylated (form I) and a N-terminus
hypophosphorylated form (form II) [16]. The C-terminus of IRF-3
contains three clusters of virus-induced phosphoacceptor sites, Ser
385/386 (Cluster I), Ser 396/398 (Cluster II) and Ser 402/405
and Thr 404 (Cluster III) that are detected as two dimeric active
forms (form III and IV) in SDS-PAGE [17,18]. Thus, to provide
further evidence that NOX2 and ROS are essential for IRF-3
activation, the effect of Tempol or NOX2 knock down through
RNAi on IRF-3 phosphorylation and dimerization was analyzed.
As shown in Figure 3A and B, SeV-induced phosphorylation of
IRF-3 at Ser 396, and to a lesser extent at Ser 398, was
Author Summary
The understanding of the mechanisms allowing the host
to mount a rapid and efficient innate immune response to
RNA viruses has been the subject of intensive research in
recent years. Major groundwork allowed the identification
of key sensors of virus nucleic acids, including RIG-I and
Mda5, which through association with the MAVS adaptor
initiate the signaling cascade required for activation of
the IRF-3 transcription factor and downstream antiviral
genes. Mechanisms of activation and degradation of key
signaling molecules allow a tight control of the intensity
and duration of the response. Our knowledge of how
redox processes regulate signaling cascades is a fast
moving field of research. Particularly, the identification
of non-phagocytic reactive oxygen species-producing
NADPH oxidase (NOX) enzymes revealed new insights
into their function in innate immunity. Our endeavor in
characterizing the role of NOX in the antiviral response
reveals a new facet to the overall picture of antiviral
response regulation. Here, we demonstrate that NOX2 is
essential for MAVS expression in airway epithelial cells,
thereby controlling the capacity of the cell to mount an
efficient innate antiviral response following recognition
of viruses.
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treated cells. In the same line, formation of the active dimeric form
of IRF-3, evaluated by native-PAGE, was also effectively impaired
(Figure 3B). Phosphorylation at Ser 386 has previously been
reported to correlate with IRF-3 in its dimeric form [18].
Accordingly, detection of Ser 386 was decreased in cells treated
with Tempol (Figure 3B). Importantly, interference with NOX2
expression similarly inhibited SeV-induced IRF-3 Ser 396, 398
and 386 phosphorylation and dimerization (Figure 3C and D).
Impairment of IRF-3 phosphorylation through interference with
NOX2 was also confirmed in the context of SeV infection of
primary cells, using normal human bronchial epithelial cells
(NHBE) (Figure 3E). Altogether, these data demonstrate that
NOX2 and ROS are essential for the efficient activation of IRF-3
during virus infection.
NOX2 is required for IKK-related kinases activation in SeV
infection
We and others have previously demonstrated that IKK-
related kinases, IKKe and TBK1, are part of the kinase activity
that is essential for IRF-3 phosphorylation and subsequent
activation of IRF-3 in the context of virus infection [5,6]. To
start depicting the role of NOX2 in the upstream signaling
pathways leading to IRF-3 activation, the role of NOX2 and
ROS in SeV-induced TBK1/IKKe expression and activity was
assessed. Initial analysis of kinases expression during SeV
infection in the absence or presence of DPI or in CTRL RNAi
vs NOX2 RNAi-transfected cells revealed that basal and SeV-
induced expression of IKKe is dramatically decreased by DPI
treatment or depletion of NOX2 expression (Figure 4A and C).
Furthermore, quantification of SeV-induced TBK1 activity
demonstrated that it is inhibited in a dose-dependent manner
by DPI-treatment reaching around 52% inhibition at a
concentration of 30 mM DPI compared to vehicle-treated cells
(Figure 4B). Finally, in NOX2 RNAi-transfected cells, SeV-
induced TBK1 activity was diminished by about 55% compared
to the activity measured in CTRL RNAi-transfected cells
(Figure 4D). These data provide important evidence for the
requirement of NOX2 in the activation of IRF-3 kinases, TBK1
and IKKe, in response to SeV infection.
Figure 1. NADPH oxidase-derived ROS are required for SeV-induced IFNb and IFIT1 genes regulation. (A–D) A549 were transfected with
the pRL-null renilla luciferase (internal control) and either the IFNb-pGL3 or ISG56-pGL3 firefly luciferase reporter constructs. At 16h post-transfection,
cells were pretreated with the indicated inhibitors (white bars), 3 mM Tempol, 1–30mM DPI (in B, a 10mM concentration was used) or 0.1–1mM Apo (in
B, a 1mM concentration was used) or the corresponding vehicle (black bars), before being left unstimulated (NS) or infected with SeV (80 HAU/10
6
cells) for 8h. Luciferase activities were expressed as fold activation over the corresponding NS condition after normalization with renilla luciferase
activities. (E) A549 were treated with 30mM DPI (white bars) or the vehicle (black bars) and then left uninfected (NS) or infected with SeV (40 HAU/10
6
cells) for 6h. Total RNA was extracted, subjected to reverse transcription and analyzed by real-time PCR using IFNb-, ISG56- and actin-specific primers.
mRNA levels are presented as absolute copy numbers of the target gene normalized versus actin mRNA used as a reference gene. (*, p,0.05;
**, p,0.01; ***, p,0.001; mean 6 SEM of triplicate experiments).
doi:10.1371/journal.ppat.1000930.g001
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A549 cells
RLRs play unique and redundant roles in RNA virus
recognition and appear to function in both cell- [19] and virus-
specific manners [20,21]. In order to further investigate the role of
NOX2 in virus-mediated IRF-3 activation, we first thought to
confirm, in our A549 model, the essential role of RIG-I in SeV
recognition that was previously highlighted in embryonic fibro-
blasts (MEFs), lung fibroblasts, dendritic cells (DCs) and 293 cells
[19,20,21,22,23]. RNAi specifically targeting RIG-I were used to
determine the role of RIG-I in IRF-3 phosphorylation. As shown
in Figure 5A, interference with RIG-I expression completely
abolished IRF-3 Ser 396 phosphorylation following SeV infection,
demonstrating that RIG-I is essential for downstream signaling to
IRF-3 in the early time points following SeV infection in A549
cells.
Kato and collaborators recently reconciled previous conflicting
results concerning the role of RIG-I and Mda5 in the recognition of
poly I:C by showing that RIG-I and Mda5 selectively recognize
short and long dsRNA, respectively [24]. Using lipid-mediated
transfection of sheared poly I:C (see experimental procedures
section for details on poly I:C preparation), we were able to
specifically trigger IRF-3 Ser 396 phosphorylation by a RIG-I-
dependent/Mda5-independent pathway (Figure 5B). Thus, activa-
Figure 2. Interference with NOX2 expression inhibits SeV-induced IFNb and IFIT1 genes transactivation. (A and B) A549 cells were
transfected with control- (CTRL; black bars) or NOX2-specific (white bars) RNAi oligonucleotides. (A) Efficiency of NOX2 knock down was monitored
by immunoblot (IB) using anti-NOX2 antibodies. Anti-tubulin antibodies were used to control equal loading. (B) At 48h post-RNAi transfection, cells
were further transfected with the IFNb-pGL3 or ISG56-pGL3 firefly luciferase and the pRL-null renilla luciferase (internal control) reporter constructs
and either left uninfected (NS) or infected with SeV (80 HAU/10
6 cells). Luciferase activities were measured and expressed as described in Figure 1. (C)
A549 cells were cotransfected with an empty control plasmid (black bars) or the myc-tagged-NOX2 (white bars) encoding plasmid and the IFNb-pGL3
firefly luciferase and the pRL-null renilla luciferase (internal control) reporter constructs. At 16h post-transfection, cells were left unstimulated or
infected with SeV for 8h and luciferase activities were measured and analyzed as described above. (D) Total RNA extracted from CTRL (black bars) and
NOX2 RNAi (white bars)-transfected A549 either left uninfected (NS) or infected with SeV (5 HAU/10
6 cells) for 5 hours were analyzed by reverse
transcription and real-time PCR using IFNb-, SeV N, and S9-specific primers. IFNb mRNA levels are presented as absolute copy numbers normalized
versus S9 mRNA used as a reference. SeV N fold expression values were determined using the DDCt method as described in Material and Methods.
(*, p,0.05; **, p,0.01; ***, p,0.001; mean 6 SEM of at least triplicate experiments).
doi:10.1371/journal.ppat.1000930.g002
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primary NHBE. (Aa n dB ), A549 were pretreated with 3mM Tempol or the corresponding vehicle for 1h. A549 cells (Ca n dD )o rN H B Ec e l l s( E)w e r e
transfected with control (CTRL) or NOX2 RNAi. (A–E) Cells were left uninfected or infected with SeV (10 HAU/10
6 cells) for the indicated times. (A, C and E)
WCE were analyzed by SDS-PAGE followed by immunoblot (IB) using anti-IRF3-Ser396 (IRF-3-P-Ser396) and anti-IRF3-Ser398 (IRF-3-P-Ser398) phosphospecific
antibodies, anti-IRF-3 and anti SeV (the nucleocapsid N is shown) antibodies. Equal loading was controlled using anti-actin antibodies. (Ba n dD ), WCE
analyzed in A and C were also resolved by native gel electrophoresis and revealed by immunoblot using anti-IRF3-Ser386 phosphospecific (IRF-3-P-Ser386)
and anti-IRF-3 antibodies. M: monomer, D: dimer. Representative immunoblots of three different experiments are shown. hpi: hours post infection.
doi:10.1371/journal.ppat.1000930.g003
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infection can be mimicked by poly I:C treatment in A549 cells.
NOX2 and ROS are essential for RIG-I mediated IRF-3
phosphorylation and dimerization
In order to further evaluate the potential role of NOX2 in the
RIG-I-dependent signaling pathway, stimulation of A549 cells
with poly I:C was performed in the absence or presence of
antioxidants or NADPH oxidase inhibitors. As shown in Figure 6A
and B, induction of the ISG56- promoter activity was significantly
reduced when poly I:C treatment was performed in the presence
of Tempol, DPI or Apo. Similarly, inhibition of NOX2 expression
by RNAi also resulted in a dramatic diminution of the capacity of
poly I:C to stimulate the IFNb- and ISG56- promoters (Figure 6C).
To further establish the role of NOX2 in IRF-3-dependent
antiviral genes expression in vivo, the expression profile of IFNb
and IFIT1 genes was analyzed by real-time PCR following poly
I:C stimulation of CTRL and NOX2 RNAi-transfected cells. As
illustrated in Figure 6D, poly I:C-induced IFNb and ISG56
mRNA levels were significantly reduced in the absence of NOX2,
as compared to control cells.
Finally, to confirm that the observed inhibition of the poly I:C-
induced IFNb and ISG56 mRNA levels was mediated by
alteration of IRF-3 activation, WCE derived from A549
transfected with CTRL or NOX2 RNAi and further stimulated
with poly I:C, were analyzed for IRF-3 phosphorylation. In cells
where NOX2 expression is significantly downregulated by RNAi,
poly I:C-induced IRF-3 phosphorylation at Ser396 was barely
detectable, while it was significantly induced in CTRL RNAi
transfected cells (Figure 7A and B). Consistently, poly I:C-induced
IRF-3 dimerization was strongly impaired in NOX2 RNAi vs
CTRL RNAi transfected cells (Figure 7C). Altogether these results
provide strong evidence that NOX2 and ROS are essential for
RIG-I-induced, IRF-3-mediated antiviral gene transcription.
Downregulation of NOX2 and superoxide scavenging
inhibit MAVS expression
Based on the observation that NOX2 downregulation and
antioxidant treatments reduced the ability of cells to mount an
efficient RIG-I mediated antiviral response through inhibition of
IRF-3 phosphorylation, the regulation of signaling molecules
upstream of IRF3 kinases was evaluated. Analysis of the expression
of known upstream signaling molecules by immunoblot revealed
that MAVS level is dramatically reduced in NOX2 vs CTRL
RNAi-transfected A549 (Figure 8A) and NHBE (Figure 8B) cells.
On the other hand, expression of RIG-I, of the ubiquitin ligase
TRIM25 that is known to regulate RIG-I activity [25], and of the
Figure 4. NOX2 is essential for IKKe expression and SeV-
induced TBK1 activity. A549 were pretreated with the vehicle or the
indicated concentrations of DPI (10–30mM) (A and B) or transfected
with CTRL or NOX2 RNAi (C and D). Cells were then left uninfected or
infected with SeV (40 HAU/10
6 cells) and harvested at different hours
post infections (hpi). (A and C), WCE were resolved by SDS-PAGE and
analyzed by immunoblot (IB) using anti-TBK1, anti-IKKe and anti-actin
antibodies. (B and D), TBK1 activity was monitored by in vitro kinase
assay using GST-IRF-3-(aa387-427). Reactions were resolved by SDS-
PAGE and IRF-3 substrate was detected by coomassie blue (CB) staining
and radioactivity incorporation (
32P). TBK1 activity was expressed as the
ratio of radioactivity incorporation over the amount of immunoprecip-
itated kinase detected by immunoblot (IB) and quantified by
densitometric analysis. Results are expressed as percentage of the
activity measured after SeV infection in respective control cells. In B,
black bars correspond to vehicle-treated cells, white bars corresponds
to DPI-treated cells. In D, black bars correspond to CTRL RNAi-tranfected
cells and white bars correspond to NOX2 RNAi-transfected cells.
(**, p,0.01; ***, p,0.001; mean 6 SEM of at least three independent
experiments).
doi:10.1371/journal.ppat.1000930.g004
Figure 5. RIG-I is essential for SeV-induced and sheared poly
I:C-induced IRF-3 activation. A549 were transfected with control
(CTRL), RIG-I or Mda5 specific RNAi oligonucleotides as indicated. (A)
A549 were further left unstimulated (NS) or infected with SeV (10HAU/
10
6 cells) for various hours post infection (hpi). (B) Cells were further
transfected with sheared poly I:C or as control, subjected to the
transfection reagent without poly I:C. WCE were resolved by SDS-PAGE
and analyzed by immunoblot (IB) using anti-IRF-3-P-Ser396, anti-IRF-3,
anti-RIG-I or anti-actin antibodies. Representative immunoblots of three
different experiments are shown.
doi:10.1371/journal.ppat.1000930.g005
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induced IRF-3 activation were similar in both conditions.
Moreover, expression of the TRAF6 ubiquitin ligase involved in
MAVS-mediated NF-kB activation, which is also placed under
NOX2 control [15], was also found to be equal in both conditions
(Figure 8A). A specific reduction of MAVS protein level was also
observed in Tempol-treated A549 cells compared to control cells
(Figure 8A). Further analysis of MAVS expression by real-time
PCR demonstrated that NOX2 downregulation by RNAi resulted
in a 55% reduction of MAVS mRNA compared with control cells
transfected with CTRL RNAi (Figure 8C). As previous reports
highlighted a key role of MAVS localization in the mitochondria
outer membrane to its function [26], and anticipating that NOX2
might regulate MAVS at different levels, the localization of the
remaining amount of MAVS was also visualized by confocal
microscopy. MAVS staining colocalized with mitochondrial
marker in both control and NOX2-depleted A549 cells
(Figure 8D), thus excluding an effect of NOX2 on MAVS function
through modulation of its subcellular localization. Taken together
these data demonstrate that in AEC, NOX2 and ROS promotes
MAVS mRNA expression.
Discussion
NOX enzymes are the main source of deliberate cellular ROS
production in response to various stimuli. Numerous studies over
the past years have increasingly clarified the function of NOX in
various biological processes, including cell proliferation, apoptosis,
proinflammatory response and host defense, notably through their
role as cellular switches that regulate signal transduction pathways
[7,8]. The importance of NOX enzymes in the innate host defense
is exemplified by the role of NOX2 in the generation of high
amount of ROS, known as oxidative burst, in phagocytic cells as
part of their armory of anti-bacterial mechanisms [27]. In this
Figure 6. NOX2 is required for RIG-I-mediated regulation of IFNb and IFIT1 genes. (A and B) A549 were cotransfected with the ISG56-pGL3
firefly luciferase and the pRL-null renilla luciferase (internal control) reporter constructs. Cells were then pretreated with 3mM Tempol, 10mM DPI,
1mM Apo (white bars) or the corresponding vehicle (black bars) before being left unstimulated (NS) or transfected with poly I:C. (C) A549 were
transfected with CTRL (black bars) or NOX2 (white bars) RNAi and were further cotransfected with the IFNb- or ISG56-pGL3 and pRL-null reporter
constructs and transfected with poly I:C for 8h. (A–C) Luciferase activities were measured and expressed as described in Figure 1. (*, p,0.05;
**, p,0.01; ***, p,0.001; mean 6 SEM of triplicates). (D) A549 were transfected with CTRL (black bars) or NOX2 specific (white bars) RNAi and left
unstimulated or transfected with poly I:C for 3h. mRNA levels of IFNb and ISG56 were analyzed by real-time PCR as described in Figure 1 after
normalization to S9 mRNA used as a reference gene. NOX2 immunoblot was performed as described in Figure 2A. (*, p,0.05; ***, p,0.001; mean 6
SEM of independent triplicates).
doi:10.1371/journal.ppat.1000930.g006
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superoxide in the innate immune antiviral response triggered
following recognition of invading virus by the RIG-I cytoplasmic
sentinel. Our data demonstrate that efficient IRF-3 activation and
downstream antiviral genes, IFIT1 and IFNb, expression in
response to SeV or RIG-I stimulation are impaired by NOX2
knock down, pharmacological inhibition of NOX or treatment
with superoxide dismutase mimetic.
Few reports previously identified a role of NOX2 in other
aspects of the cellular response to virus infections. NOX2 was
recently shown to mediate HIV Tat-induced JNK activation and
cytoskeletal rearrangement in HUVEC [28]. Moreover, Paramyx-
oviridae virus-induced NF-kB activation and downstream proin-
flammatory cytokines production in AEC were shown to be
dependent on NOX2 [15]. Reduced inflammation of lung
parenchyma has also been noticed during influenza infection in
mice lacking NOX2 murine homolog [29]. However, this study
does not distinguish between a role of NOX2 in phagocytes
recruited to the lung parenchyma from a potential role of NOX2
in non-phagocytic cells. Earlier reports suggested NOX-dependent
IRF-3 activation in response to Respiratory Syncitial Virus (RSV),
but this conclusion was only based on an inhibitory effect of DPI
or Apo treatment [30]. Based on the previous demonstration that
RSV-induced IRF-3 activation is triggered by a RIG-I-dependent
recognition mechanism [31] and our recent observation that
NOX2 is involved in RSV-mediated NF-kB activation in AEC
[15], the role of NOX2 in RIG-I-mediated activation of IRF-3,
presented in this study, provides a likely mechanism for this yet
unexplained redox-dependent activation of IRF-3 during RSV
infection.
Beside RLH receptors, viral nucleic acids are also sensed by
members of the Toll-like receptor (TLR) family, including TLR-3
that binds extracellular or endosomal dsRNA [1]. Exogenous
H2O2 treatment was recently shown to enhance TLR-3 mediated
NF-kB, but not IRF-3, activation [32]. This result suggests that
redox-dependent regulation of IRF-3 following recognition of viral
RNA is not a universal mechanism, but depends on the PRR
engaged following virus infection. However, it is also important to
consider that the use of exogenous H2O2 constitute a major
difference with our study. Indeed, not only the subtype of ROS,
but also the localization of the ROS signal at specific subcellular
compartment, is considered essential for activating specific redox
signaling events [33,34]. Thus, the effect of exogenously added
H2O2 most likely differs from the role of endogenous NOX2-
dependent superoxide studied here. Interestingly, IRF3 activation
following TLR-4 stimulation with LPS stimulation in U373/CD14
Figure 7. NOX2 depletion inhibits poly I:C-induced IRF-3 phosphorylation and dimerization. CTRL- and NOX2-RNAi-transfected A549
were subjected to mock or poly I:C transfection for the indicated times. (A) WCE were resolved by SDS-PAGE. Efficiency of NOX2 depletion by NOX2-
RNAi was evaluated by immunoblot (IB) using tubulin detection as a loading control. On a separate gel, WCE were analyzed by IB using anti-IRF-3-P-
Ser396, anti-IRF-3 and anti-actin antibodies. (B) WCE were resolved by native gel electrophoresis and immunoblotted with anti-IRF-3 antibodies.
Representative immunoblots of three different experiments are shown. hpi: hours post infection. M: monomer, D: dimer.
doi:10.1371/journal.ppat.1000930.g007
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NOX family, NOX4 [35]. In this study, NOX4 appears to play a
role in an ASK1/p38 axis that leads to IRF-3 nuclear
accumulation. However, whether NOX4 is also involved in the
TBK1/IKKe pathway that was shown to be involved in LPS-
induced IRF-3 activation in macrophages [36] has not yet been
investigated. In the present study, a role of NOX4 in the RIG-I-
mediated IRF-3 activation was excluded based on the absence of
detection of NOX4 expression in the A549 cell model used, as
previously described [15].
Recently, a role of ROS in RLR signaling was documented in
Atg5
2/2 MEF cells that are defective in autophagy process. ROS
associated with the accumulation of dysfunctional mitochondria in
these cells enhanced RLR-mediated cytokines production [37]. In
the same study, rotenone treatment, which artificially induces
accumulation of mitochondria-associated ROS, was sufficient to
enhance RLR signaling [37]. However, it is not yet clear how this
ROS-dependent mechanism is involved in RLR signaling
regulation in normal cells exhibiting functional autophagy and if
the effect of mitochondria-associated ROS is associated with
increased IRF-3 activation. This production of ROS at a non-
physiological level is considered harmful, and therefore might
represent more a deleterious mechanism involved in virus
pathogenicity than a physiological regulation of RLR signaling
as illustrated by our results. Other studies also presented evidence
of a cross-talk between NOX2 and mitochondria-associated ROS
in the regulation of signaling cascades. In human umbilical vein
endothelial cells and human alveolar macrophages, TNFa-
induced NF-kB activation was shown to be dependent on both
NOX2 and the mitochondrial respiratory chain activity [38,39].
Thus, one may not exclude at this point that both the NOX2-
dependent and a mitochondria-associated mechanism might
cooperate in the regulation of RIG-I-mediated activation of the
antiviral response.
Since NOX2 knock down alters phosphorylation of multiple
phosphoacceptor sites, including Ser 386, Ser 396 and Ser 398 in
the C-terminal clusters of IRF-3, it likely plays a role in several
pathways converging to IRF-3 activation downstream of RIG-I.
Our data demonstrate that NOX2 is required for TBK1 catalytic
activation and IKKe expression. Recent studies strongly suggest
that TBK1 and IKKe specifically phosphorylate Ser 402 and Ser
396 of IRF-3 [40,41,42], thereby implying that yet unidentified
kinases that are responsible for the phosphorylation of other
critical phosphoacceptor sites might also be controlled by NOX2.
Figure 8. NOX2 downregulation or ROS scavenging diminishes MAVS mRNA expression without affecting its subcellular
localization. (A, B) WCE derived from A549 (A) and NHBE (B) cells transfected with control (CTRL) or NOX2 RNAi or treated with vehicle or 3mM
Tempol were analyzed by immunoblot using anti-RIG-I, anti-MAVS, anti-TRIM25, anti-TRAF3, anti-TRAF6 and anti-actin antibodies. MAVS was detected
as two different splice variants as described in [66]. Representative immunoblots of at least three different experiments are shown. (C) Total RNA
extracted from A549 transfected with CTRL and NOX2 RNAi were analyzed by real time PCR as described in Figure 1. MAVS mRNA levels are expressed
as absolute values after normalization to S9 mRNA used as a reference gene. (*, p,0.05; mean 6 SEM of independent triplicates). (D) A549 cells
transfected with CTRL and NOX2 RNAi were fixed and mitochondria were stained using Mitotracker (red; panel b and e). After permeabilization, MAVS
was stained using anti MAVS antibodies and Alexa488-secondary antibodies (green; panel a and d). Images were overlaid to observe colocalization
(panel c and f). Images are representative of 2 experiments performed in triplicate.
doi:10.1371/journal.ppat.1000930.g008
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JNK [46], were shown to be involved in IRF-3 phosphorylation,
but whether these kinases directly target IRF-3, and if so, on which
specific phosphoacceptor sites, has not yet been established.
The observation that NOX2 knock down and antioxidant
treatment abrogated RIG-I mediated IRF-3 phosphorylation raised
the questionabout the identity of the molecular target(s) in the RIG-
I-induced signaling cascade. Our data demonstrate that in AEC,
NOX2 is essential for expression of the MAVS adaptor, which acts
as a central platform to catalyze the formation of the mito-
signalosome containing, among other signaling molecules, RIG-I
and TRAFs involved in the antiviral cascade [47]. ROS and
NADPH oxidases are known to regulate mRNA expression by
several means, including regulation of redox-sensitive transcription
factors, such as NF-kB and AP-1 [48,49] and modulation of mRNA
stability as reported elsewhere for TLR-4, IL-1 or p53 mRNA
[26,50,51]. Interestingly, NOX2 was specifically shown to regulate
cell cycle via induction of p21
cip1 mRNA expression in endothelial
cells following nutrient deprivation [52]. The transcriptional and
post-transcriptional mechanisms involved in MAVS mRNA
expression have not yet been elucidated. Further studies are
required to identify these mechanisms and uncover how NOX2 is
involved in their regulation.
Function of NOX2-derived ROS under basal conditions was
previously documented in other non-phagocytic cells [53,54,55].
Particularly, an active NOX2-containing NADPH oxidase is well
documented to contribute to endothelial cells proliferation [53,54].
It is worth mentioning that during the course of our study,
Takemura and Collaborators identified a role of NOX2 in the
regulation of basal and EGF-induced ENac channel activity in
alveolar epithelial cells [56]. Our data describe the essential role of
NOX2 and ROS in basal MAVS mRNA and protein expression.
However, during virus infection, MAVS is proteolysed by a
proteasome-dependent PCBP2/AIP4 axis [57]. Thus, it is an
interesting working hypothesis that NOX2-dependent mechanism
might permit expression of MAVS during virus infection to
regenerate the pool of available MAVS in the cell to mount a
sustained antiviral response. Studies are underway to characterize
in detail basal and virus-induced NOX2 activity. To date, NOX2
subcellular localization in non-phagocytic cells appears to vary
from cell type to cell type, being either at the plasma membrane, in
the endosomes responsible for early receptor-mediated signaling,
known as ‘‘redoxisomes’’, or in the perinuclear region [58]. An
interesting aspect of these studies will be to determine the
localization of NOX2 and ROS production involved in MAVS
expression, as this is now considered an important aspect in the
specificity of redox-dependent functions [59].
Materials and Methods
Reagents
DPI, DMSO and BSA were purchased from Sigma-Aldrich.
Apo was purchased from Calbiochem. Tempol was from Biomol
International. Oligonucleotide primers were purchased from
Invitrogen (Carlsbad, USA) or Alpha DNA (Montreal, Canada).
RNAi oligonucleotides were from Dharmacon. Target sequences
of the RNAi used against the different genes are as followed:
CTRL,
59cauagcguccuugatcaca
39; NOX2,
59gaagacaacuggacag-
gaa
39; RIG-I,
59aacgauuccaucacuauccau
39; Mda5,
59ggugaaggag-
cagauucag
39.
Plasmids
The pRL-null reporter plasmid was obtained from Promega.
ISG56-pGL3 and IFNb-pGL3 luciferase reporter constructs and
GST-IRF-3(aa387-427)-pGex-KG expression plasmid were previ-
ously described [4,5]. Plasmids used to establish Real-Time PCR
standard curves were generated by cloning of the PCR-amplified
+208 to +706nt fragment of the IFNb transcript (NM_002176),
the +335 to +1319nt fragment of the IFIT1 transcript
(NM_001548), the +748 to +980nt fragment of the b-actin
transcript (NM_001101) and the +57 to +652nt fragment of the
ribosomal S9 transcript (NM_001013) into the pCR2.1-TOPO
using EcoRI. The pCS2-myc-NOX2 construct encoding myc-
tagged human NOX2 was a kind gift from Dr. Shah, King’s
College London [60]. The pcDNA3.1-myc-MAVS construct was
previously described [61].
Cell culture and infections
A549 cells (ATCC) were cultured in F12 Nutrient Mixture
(Ham) medium (Gibco) supplemented with 10% heat-inactivated
Fetal Bovine Serum (HI-FBS, Gibco) and 1% L-Glutamine
(Gibco). Normal human bronchial epithelial cells (NHBE) were
obtained from Lonza, cultured in BEGM medium (Lonza) and
used between passage 2 and 4. Sendai virus Cantell strain was
obtained from Charles River Laboratories. Infection of subcon-
fluent cells was performed at 10–80HAU/10
6 cells depending on
the experiments for the indicated times. Where indicated, DPI,
Apocynin or Tempol (or the corresponding vehicle) were added 1h
before infection in serum free medium (SFM). Infection was
pursued for 2h in SFM before addition of HI-FBS.
Stimulation with poly I:C
The synthetic analog of dsRNA, polyinosine-polycytidylic acid
(poly I:C) (InvivoGen, San Diego CA) was resuspended at 10 mg/
ml in sterile PBS and annealed by heating at 56uC for 30 min
before cooling down at RT until it reached 20uC. Before use, poly
I:C was diluted to 1mg/mL with ice-cold PBS and sheared using a
26G syringe. Cells were then transfected using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
RNAi oligonucleotides and plasmid transfections and
luciferase assays
RNAi oligonucleotides and plasmid transfections were per-
formed using the oligofectamine reagent (Invitrogen) and the
TransIT-LT1 Transfection Reagent (Mirus), respectively, and
luciferase assays were performed using the Dual Luciferase
reporter assay (Promega) as previously described in [15].
Immunoblot analysis
Whole cell extracts (WCE) were prepared on ice in Nonidet P-40
(Igepal, SIGMA) lysis buffer [15] and quantified using the Bio-Rad
Protein Assay (Biorad, Hercules CA). 30mg were subjected to SDS-
PAGE electrophoresis followed by immunoblot analysis using
anti-IRF-3-phosphoSer396 [62], anti-IRF-3-phosphoSer398 [36],
anti-IRF-3 (Active Motif), anti-TBK1 (Imgenex), anti-IKKe
(eBioscience), anti-MAVS (Alexis Biochemicals), anti-RIG-I (Alexis
Biochemicals), anti-TRAF3 (santa-cruz), anti-TRAF6 (santa-cruz),
anti-TRIM25 (BD transduction laboratories), anti-actin (Chemicon
International) and anti-SeV (obtained from Dr. J. Hiscott, McGill
University, Montreal, Canada) antibodies dilutedin PBS containing
0.5% Tween and either 5% nonfat dry milk or 5% BSA.
For NOX2 detection, A549 were scraped directly in 125mM
Tris-HCl (pH 6.8), 10% glycerol, 2% SDS, 0.1 M DTT buffer
containing 10mg/ml leupeptin, 20mg/ml aprotinin and 1mM
pepstatin. Lysis was pursued at RT for 15 min before sonication.
After 10 min at 70uC, samples were quantified using RC-DC
protein quantification assay (BioRad). 150mg of lysate proteins
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anti-gp91phox-Cter (obtained from Dr. Dagher and Dr. Brando-
lin, CEA-Grenoble, Grenoble, France) and anti-tubulin (Santa-
Cruz) antibodies.
Immunoreactive bands were visualized by enhanced chemilu-
minescence using the Western Lightning Chemiluminescence
Reagent Plus (Perkin Elmer Life Sciences). In between phosphos-
pecific- and anti-IRF-3-antibodies, the membrane was stripped in
0.2% SDS, 62.5 mM Tris-HCl pH 6.8, 0.1 mM b-mercaptoeth-
anol for 20 minutes at 50uC.
Dimerization assay
Native-PAGE was conducted as described previously [63] using
8mg WCE prepared as described above. Immunoblot detection of
IRF-3 was performed using anti-IRF-3-phospho-386 (1/200, IBL)
or anti-IRF-3 (Active Motif) antibodies.
In vitro kinase assays
In vitro kinase assays were conducted as described previously
[42], using 80mg of WCE immunoprecipitated using 1mg of TBK1
antibodies (obtained from Dr. T. Maniatis, Harvard, USA) and
1mg of recombinant GST-IRF-3 (aa387-427) protein produced in
BL21(DE3)plysS following IPTG stimulation as previously de-
scribed [64]. After resolution by SDS-PAGE, IRF-3-GST was
detected by coomassie blue staining of the lower part of the gel and
radioactivity incorporation (
32P) was quantified using a Typhoon
Trio apparatus (Amersham Biosciences). The upper part of the gel
was transferred to nitrocellulose membrane and TBK1 was
detected using anti-TBK1 antibodies (Imgenex).
RNA extraction and real-time PCR
Total RNA was prepared using the RNAqueous-96 Isolation
Kit (Ambion) following the manufacturer’s instructions without the
included DNase1 treatment step. Total RNA (1mg) was subjected
to reverse transcription using the QuantiTect Reverse Transcrip-
tion Kit (Qiagen), which includes a genomic DNA removal step.
PCR amplifications were performed using the QuantiTect SYBR
Green Kit (Qiagen) or the Fast start SYBR Green Kit (Roche) in
the presence of 0.4mM of ISG56-, IFNb-, b-actin- or –S9 specific
primers. Absence of genomic DNA contamination was analyzed
using a reaction without reverse transcriptase. Sequences of primer
used are as follows: - ISG56, S: gcccagacttacctggacaa, AS:
ggttttcagggtccacttca- IFNß, S: gaactttgacatccctgaggagattaagcagc,
AS: gttccttaggatttccactctgactatggtcc- SeV N, S: agtatgggaggacca-
cagaatgg, AS: ccttcaccaacacaatccagacc- MAVS, S: ggtgccatc-
caaagtgcctacta, AS: cagcacgccaggcttactca- S9, S: cgtctcgaccaa-
gagctga, AS: ggtccttctcatcaagcgtc- Actin, S: acaatgagctgctggtggct;
AS: gatggccacagtgtgggtga. Detection was performed on a Rotor-
Gene 3000 Real Time Thermal Cycler (Corbett Research). For
ISG56, IFNb, actin and S9, standard curves were obtained using
amplification of serial dilutions of pCR2.1-TOPO-ISG56, -IFNb,
-b-actin and –S9 plasmids. ISG56 and IFNb data represent
absolute mRNA copy numbers normalized to b-actin or S9 used
as a reference gene. For SeV N expression, standard curves and
PCR efficiencies were obtained using serial dilutions of cDNA
prepared from positive control infected cells and data are
presented as relative fold expression versus uninfected sample
after normalization to S9. Relative fold expression values were
determined applying the DDCt method [65].
Confocal immunofluorescence imaging
A549 cells were grown and transfected with RNAi oligonucle-
otides on glass coverslips. At 48h post-transfection, mitochondria
were visualized with 100nM Mitotracker Red CMX ROS
(Invitrogen) applied to cells for 30 minutes at 37C. Cells were
subsequently washed, fixed with 3.7% formaldehyde for 15 min-
utes at 37C and permeabilized with 0.2% triton X-100. Cells were
then blocked in 10% goat serum before incubation for 3h with
anti-MAVS (Alexis Biochemicals) diluted in PBS containing 3%
BSA. After washing, cells were incubated for 1h with anti-rabbit
Alexa488 secondary antibody (Invitrogen) diluted in PBS contain-
ing 3% BSA. Cells were then washed and mounted with ProLong
Antifade reagent (Invitrogen). Single plane images were acquired
with a Leica SP5 confocal microscope equipped with 636(1.7 NA)
oil objective with a digital zoom of 26.
Statistical analyses
Data are presented as the mean 6 standard error of the mean
(SEM). Statistical significance for comparison of two means was
assessed by an unpaired Student’s t test. For dose-dependent
experiments or multiple inhibitor studies, a one-way analysis of
variance (ANOVA) test was used followed by a Dunnett post-test.
Analyses were performed using the Prism 5 software (GraphPad).
Statistical relevance was evaluated using the following p values:
p,0.05 (*), p,0,01 (**) or p,0,001 (***).
Accession numbers
Please see Table 1 for accession numbers.
Supporting Information
Text S1 Supporting information
Found at: doi:10.1371/journal.ppat.1000930.s001 (0.03 MB
DOC)
Figure S1 Effect of Tempol, Apocynin and DPI on the pEF1
unrelated promoter. A549 were transfected with the pRL-null
renilla luciferase (internal control) and either the pEF1-Luc firefly
luciferase reporter constructs. At 16h post-transfection, cells were
pretreated with the following inhibitors (white bars), 3 mM
Tempol, 10mM DPI or 1mM Apo or the corresponding vehicle
(black bars), before being left unstimulated (NS) or infected with
SeV (80 HAU/10
6 cells). Luciferase activities were normalized
over renilla luciferase activities (mean+/2 SEM of triplicate
experiments).
Found at: doi:10.1371/journal.ppat.1000930.s002 (0.08 MB TIF)
Figure S2 Cell viability of CTRL- vs NOX2-RNAi transfected
A549. A549 were transfected as described with control (CTRL) or
NOX2 specific RNAi. At 48h post-transfection, viable and non-
viable cells were quantified by trypan blue exclusion assay. Data
Table 1. Accession numbers.
mRNA Protein
IRF-3 NM_001571.4 NP_001562.1
RIG-I NM_014314.3 NP_055129.2
MAVS NM_020746.3 NP_065797.2
TBK1 NM_013254.2 NP_037386.1
IKKe NM_014002.2 NP_054721.1
TRIM25 NM_005082.4 NP_005073.2
TRAF3 NM_003300.2 NP_003291.2
TRAF6 NM_004620.2 NP_004611.1
doi:10.1371/journal.ppat.1000930.t001
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SEM of triplicate experiments).
Found at: doi:10.1371/journal.ppat.1000930.s003 (0.09 MB TIF)
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